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A B S T R A C T
Background
Antibiotic resistance is a worldwide health threat. Interventions that reduce antibiotic prescribing by clinicians are expected to reduce
antibiotic resistance. Disparate interventions to change antibiotic prescribing behaviour for acute respiratory infections (ARIs) have
been trialled and meta-analysed, but not yet synthesised in an overview. This overview synthesises evidence from systematic reviews,
rather than individual trials.
Objectives
To systematically review the existing evidence from systematic reviews on the effects of interventions aimed at influencing clinician
antibiotic prescribing behaviour for ARIs in primary care.
Methods
We searched the Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects (DARE), MEDLINE, Embase,
CINAHL, PsycINFO, and Science Citation Index to June 2016. We also searched the reference lists of all included reviews. We ran a
pre-publication search in May 2017 and placed additional studies in ’awaiting classification’.
We included both Cochrane and non-Cochrane reviews of randomised controlled trials evaluating the effect of any clinician-focussed
intervention on antibiotic prescribing behaviour in primary care. Two overview authors independently extracted data and assessed the
methodological quality of included reviews using the ROBIS tool, with disagreements reached by consensus or by discussion with a
third overview author. We used the GRADE system to assess the quality of evidence in included reviews. The results are presented as a
narrative overview.
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Main results
We included eight reviews in this overview: five Cochrane Reviews (33 included trials) and three non-Cochrane reviews (11 included
trials). Three reviews (all Cochrane Reviews) scored low risk across all the ROBIS domains in Phase 2 and low risk of bias overall.
The remaining five reviews scored high risk on Domain 4 of Phase 2 because the ’Risk of bias’ assessment had not been specifically
considered and discussed in the review Results and Conclusions. The trials included in the reviews varied in both size and risk of bias.
Interventions were compared to usual care.
Moderate-quality evidence indicated that C-reactive protein (CRP) point-of-care testing (risk ratio (RR) 0.78, 95% confidence interval
(CI) 0.66 to 0.92, 3284 participants, 6 trials), shared decision making (odds ratio (OR) 0.44, 95%CI 0.26 to 0.75, 3274 participants, 3
trials; RR 0.64, 95% CI 0.49 to 0.84, 4623 participants, 2 trials; risk difference -18.44, 95% CI -27.24 to -9.65, 481,807 participants,
4 trials), and procalcitonin-guided management (adjusted OR 0.10, 95% CI 0.07 to 0.14, 1008 participants, 2 trials) probably reduce
antibiotic prescribing in general practice.We foundmoderate-quality evidence that procalcitonin-guided management probably reduces
antibiotic prescribing in emergency departments (adjusted OR 0.34, 95% CI 0.28 to 0.43, 2605 participants, 7 trials). The overall
effect of these interventions was small (few achieving greater than 50% reduction in antibiotic prescribing, most about a quarter or
less), but likely to be clinically important.
Compared to usual care, shared decision making probably makes little or no difference to reconsultation for the same illness (RR 0.87,
95%CI 0.74 to 1.03, 1860 participants, 4 trials, moderate-quality evidence), and maymake little or no difference to patient satisfaction
(RR 0.86, 95% CI 0.57 to 1.30, 1110 participants, 2 trials, low-quality evidence). Similarly, CRP testing probably has little or no effect
on patient satisfaction (RR 0.79, 95% CI 0.57 to 1.08, 689 participants, 2 trials, moderate-quality evidence) or reconsultation (RR
1.08, 95% CI 0.93 to 1.27, 5132 participants, 4 trials, moderate-quality evidence). Procalcitonin-guided management probably results
in little or no difference in treatment failure in general practice compared to normal care (adjusted OR 0.95, 95% CI 0.73 to 1.24,
1008 participants, 2 trials, moderate-quality evidence), however it probably reduces treatment failure in the emergency department
compared to usual care (adjusted OR 0.76, 95% CI 0.61 to 0.95, 2605 participants, 7 trials, moderate-quality evidence).
The quality of evidence for interventions focused on clinician educational materials and decision support in reducing antibiotic
prescribing in general practice was either low or very low (no pooled result reported) and trial results were highly heterogeneous,
therefore we were unable draw conclusions about the effects of these interventions. The use of rapid viral diagnostics in emergency
departments may have little or no effect on antibiotic prescribing (RR 0.86, 95% CI 0.61 to 1.22, 891 participants, 3 trials, low-
quality evidence) and may result in little to no difference in reconsultation (RR 0.86, 95% CI 0.59 to 1.25, 200 participants, 1 trial,
low-quality evidence).
None of the trials in the included reviews reported on management costs for the treatment of an ARI or any associated complications.
Authors’ conclusions
We found evidence that CRP testing, shared decision making, and procalcitonin-guided management reduce antibiotic prescribing
for patients with ARIs in primary care. These interventions may therefore reduce overall antibiotic consumption and consequently
antibiotic resistance. There do not appear to be negative effects of these interventions on the outcomes of patient satisfaction and
reconsultation, although there was limited measurement of these outcomes in the trials. This should be rectified in future trials.
We could gather no information about the costs of management, and this along with the paucity of measurements meant that it was
difficult to weigh the benefits and costs of implementing these interventions in practice.
Most of this research was undertaken in high-income countries, and it may not generalise to other settings. The quality of evidence
for the interventions of educational materials and tools for patients and clinicians was either low or very low, which prevented us from
drawing any conclusions. High-quality trials are needed to further investigate these interventions.
P L A I N L A N G U A G E S U M M A R Y
Strategies to help doctors change the way they prescribe antibiotics for patients with acute respiratory infections
Overview question
This overview aimed to summarise all evidence from systematic reviews on strategies directed at doctors to reduce the antibiotic
prescriptions they give to patients with acute respiratory infections (ear, nose, throat or chest infections).
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Background
It is important that antibiotics are used for illnesses where they can make a difference to patients’ symptoms and recovery and that they
are available for those infections that are serious and can lead to disability or death. Antibiotics may make very little or no difference for
patients who have ear, nose, throat, or chest infections that are caused by a virus (e.g. a cold, flu, or sore throat). Doctors can prescribe
antibiotics too readily for patients with these symptoms. Strategies to change doctors’ antibiotic prescribing habits have been developed
to reduce the number of antibiotics given to patients with these symptoms. Several types of strategies exist, and it is important to bring
together all the information on how these work.
Study characteristics
We identified five Cochrane Reviews and three non-Cochrane reviews. The reviews varied in how many trials they included and the
number of participants within trials. The quality of both the reviews and trials varied.
Key results
We found moderate-quality evidence that three types of strategies probably help to reduce antibiotic prescribing in primary care. Strate-
gies that encourage the use of shared decision making between doctors and their patients, C-reactive protein tests, and procalcitonin-
guided management (both tests that measure the amount of proteins in the blood, which may be raised in the case of infection) all prob-
ably reduce antibiotic prescribing in general practice. Procalcitonin-guided management also probably reduces antibiotic prescribing in
emergency departments. These strategies seem to change antibiotic prescribing whilst keeping patients happy with their consultation
and ensuring that they did not need to return to their doctor for the same illness. There was no information about the cost of these
strategies, so it was difficult to weigh up the benefits and costs.
The quality of the evidence for strategies that aim to educate doctors about antibiotic prescribing, that provide decision aids for doctors
to help them change their prescribing, and for the use of rapid viral diagnostics in emergency departments was either low or very low,
meaning that we were unable to draw firm conclusions about the effects of these strategies.
In conclusion, we determined that some strategies aimed at doctors can probably help to reduce antibiotic prescribing in primary care.
Further studies are needed for other types of strategies where there is less information about whether they can change prescribing.
B A C K G R O U N D
Description of the condition
Antibiotic resistance is a major threat to human health world-
wide (WHO 2015). Two million people are directly affected by
antibiotic-resistant infections, of whom 23,000 die, annually in
the USA (CDC 2013), with similar numbers in Europe (Lancet
2009). Infections caused by drug-resistant bacteria put patients at
increased risk of worse clinical outcomes and death, and consume
more healthcare resources (WHO 2015). The economic cost has
been estimated at USD 55 billion per year in the USA, although
the real cost may be much higher (Smith 2013). Unless addressed,
this situation will worsen, with 10 million deaths estimated glob-
ally every year by 2050, and economic costs of USD 100 trillion
from a reduction in overall economic production (O’Neill 2014).
Antibiotic resistance is an inevitable consequence of antibiotic use
because antibiotics kill only bacteria that are sensitive and not
pre-existing antibiotic-resistant bacteria (Spellberg 2013). Glob-
ally, human consumption of antibiotics increased by 36% between
2000 and 2010 (Van Boeckel 2014). This is reflected in European
increases in antibiotic prescriptions (Adriaenssens 2011). In the
UK, 949.9 tonnes of antibiotics were used in 2013, with 56% be-
ing for human, rather than animal, use (PHE 2013). In Australia,
47% of the population are prescribed at least one antibiotic ev-
ery year (ACSQHC 2016). For the individual patient, recent an-
tibiotic use is the single most important risk factor for antibiotic-
resistant infection (Chung 2007; Malhotra-Kumar 2007), with
longer and multiple courses of antibiotics associated with even
higher rates of resistance (Costelloe 2010). No new classes of an-
tibiotics have been developed in the last two decades, and urgent
investment in the discovery and development of new antimicro-
bial drugs has been proposed (Huttner 2013; O’Neill 2014).
However, resistance is reversible: in individuals, stopping the use
of antibiotics results in the exponential decay of resistance in the
bacteria of their microbiome (Costelloe 2010). This supports the
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case for strategies that promote more prudent use of antibiotics
(O’Neill 2014). There are various approaches to this, including:
promotion of narrow- over broad-spectrum antibiotics; prescrib-
ing the shortest clinically effective course; and achieving a total
reduction in antibiotics prescribed.
Most antibiotics are prescribed in primary care, and most com-
monly for acute respiratory infections (ARIs) (Goossens 2005;
Gulliford 2014; Shapiro 2014). Antibiotics are highly effective for
some ARIs (including community-acquired bacterial pneumonia
and acute exacerbation of chronic obstructive pulmonary disease
(COPD)). However, the vast majority of ARIs are seen in pri-
mary care and in most cases are spontaneously resolved without
antibiotics. These ARIs derive only marginal clinical benefits from
antibiotics, which have to be balanced against the increased risks
of harms associated with mild adverse events, and antibiotic resis-
tance. Treatedwith antibiotics, one-third fewer childrenwith acute
otitis media had pain at days 2 to 3 (number needed to treat for an
additional beneficial outcome (NNTB) = 20) (Venekamp 2015),
and the duration of sore throat and acute bronchitis (cough) was
reduced by 12 to 16 hours (NNTB to prevent one sore throat =
21) (Smith 2014; Spinks 2013). Meanwhile, the risk of vomiting,
diarrhoea, or rash increased (number needed to treat for an addi-
tional harmful outcome (NNTH) = 9 for acute otitis media, and
NNTH = 24 for acute bronchitis).
The management of ARIs in primary care is therefore a key target
for influencing the antibiotic prescribing behaviour of clinicians.
This is most often done by encouraging reduced prescribing of
antibiotics for ARI. The use of delayed prescriptions by clinicians
can also change both clinician and patient behaviour by changing
the type of prescription written and decreasing the likelihood that
an antibiotic prescription is used.
Description of the interventions
Many interventions that target clinicians also frequently target pa-
tients or the public, acknowledging the influence of patient ex-
pectations and concerns on prescribing. However, in many coun-
tries an antibiotic cannot be prescribed without the prescribing
clinician’s consent. In addition, the type of prescription written,
whether it is for immediate or delayed use, is also the clinician’s
decision and should be considered as an additional, distinct type of
prescribing behaviour. This overview focussed on two prescribing
behaviours, that is whether an antibiotic is:
1. prescribed;
2. prescribed for immediate or delayed use.
We focussed on interventions aimed at influencing primary care
clinicians’ antibiotic prescribing behaviour for patients with ARIs.
We have included all ARIs, acknowledging that antibiotic pre-
scribing for some conditions (such as bacterial pneumonia and
mastoiditis) is entirely appropriate for all cases, while for others
(such as acute otitis media, sore throat, acute bronchitis, and acute
sinusitis) antibiotic prescribing may be useful for only a propor-
tion. The interventions could have included:
1. educational materials for clinicians: printed, electronic, or
audio-visual materials that target the healthcare professional;
2. educational meetings: healthcare professionals attending
conferences, lectures, training courses, or workshops;
3. educational outreach visits: healthcare professionals
receiving information from a trained professional in their
practice setting;
4. audit and feedback: any summary of clinical performance
of health care over a specified time period provided to the
healthcare professional;
5. reminders: verbal, written, or electronic information
intended to prompt a healthcare professional to recall
information, to include (computer) decision support systems;
6. financial interventions: targeting the healthcare professional
to include financial incentives (e.g. fee-for-service) and financial
penalties (e.g. direct or indirect financial penalty for
inappropriate behaviour);
7. point-of-care tests (POCTs): equipment for use by
healthcare professionals in their practice setting, to be used at the
time and place of patient care, to provide rapid diagnostic
information to help reduce the uncertainty associated with
clinical diagnosis;
8. communication strategies: any resource targeted at the
healthcare professional that encourages discussion with a patient
about management options including:
i) clinician-delivered patient educational interventions;
ii) improved communication interventions (for clinician-
patient interaction);
iii) shared decision making (as defined by Coxeter 2015,
i.e. the process of enabling a health professional and patient to
make a joint decision about management based on the best
available evidence and the patient’s values and preferences);
9. mass media campaigns: targeted at the healthcare
professional at the population level employing varied use of
communication;
10. delayed prescription strategy: any resource targeted at the
healthcare professional that encourages giving a prescription for a
patient to collect or use later than the initial consultation if
symptoms do not improve;
11. any other intervention targeted at the clinician and aimed
at changing antibiotic prescribing behaviour.
How the intervention might work
Strategies targeting clinician behaviour are complex interventions,
meaning there is no single proposed mechanism of action. Mul-
tiple factors influence clinician antibiotic prescribing behaviour:
knowledge of guidelines, previous clinical experience, diagnostic
uncertainty, workload, and perceived patient expectations for an-
tibiotics (Tonkin-Crine 2011).
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Interventions may provide education (including professional con-
tinuing education, provision of guidelines, decision support, edu-
cational outreach visits, audit and feedback, and patient informa-
tion leaflets) to fill knowledge gaps and misperceptions. Interven-
tions may seek to tackle diagnostic uncertainty by providing more
information to the clinician and thus increasing self efficacy in
managing the patient (e.g. through use of POCTs). Interventions
may also seek to encourage enhanced communication between
clinician and patient to discuss the benefits and harms of antibiotic
treatment, thus decreasing concerns about negatively affecting pa-
tient satisfaction (e.g. shared decision making, enhanced commu-
nication skills training). Different combinations of these might be
expected to achieve a greater effect if they operate through differ-
ent mechanisms (Arnold 2005).
Much of the research undertaken hitherto has examined the ef-
fect of interventions, with less emphasis on process evaluation,
which examines how interventions work (or do not work) (Moore
2015).Where process evaluations have been carried out, interven-
tions that support general practitioners to use C-reactive protein
(CRP) POCTs or communication skills training, or both, appear
to be effective because they increased the perceived importance of
reducing antibiotic prescribing and decreased concerns regarding
the safety of reducing antibiotic prescribing (Yardley 2013).
Why it is important to do this overview
Antibiotic prescribing is a major driver for the development of an-
tibiotic-resistant infections. Antibiotics are commonly prescribed
in themanagement of ARIs in primary care, despite good evidence
that they are only weakly effective in the vast majority.
There are many interventions aimed at influencing antibiotic pre-
scribing for ARIs. However, the multiple systematic reviews evalu-
ating their effectiveness have not been synthesised. This overview
aimed to synthesise evidence from systematic reviews (rather than
individual trials) and assess the effectiveness of these interventions
to enable policymakers as well as clinicians to design processes for
future management of antibiotic resistance in primary care, and
researchers to focus on any gaps in the current evidence.
O B J E C T I V E S
To systematically review the existing evidence from systematic re-
views on the effects of interventions aimed at influencing clinician
antibiotic prescribing behaviour for ARIs in primary care.
M E T H O D S
Criteria for considering reviews for inclusion
Types of reviews
We included all published systematic reviews (Cochrane and non-
Cochrane) of randomised controlled trials (RCTs) (including par-
allel-group, cluster, and factorial) testing interventions aimed at
changing antibiotic prescribing in primary care for ARIs. We in-
cluded reviews that included primary studies of non-RCT designs,
but only where RCT data were reported separately, where indi-
vidual study data could be obtained. As stated in our protocol, we
excluded reviews when there was complete overlap with an exist-
ing included review (overview authors decided which review to in-
clude, with Cochrane Reviews given priority over non-Cochrane
reviews, as they reportedmore detail) andwhere reviewswere rated
as having a high risk of bias.
Types of participants
We included reviews that studied interventions targeted at the an-
tibiotic prescribing behaviour of clinicians for the treatment of
ARIs in primary care. We included all ARIs, acknowledging that
antibiotic prescribing for some conditions (such as bacterial pneu-
monia and mastoiditis) is entirely appropriate for all cases, while
for others (such as acute otitis media, sore throat, acute bronchi-
tis, and acute sinusitis) antibiotics prescribing may be useful for
only a proportion of patients. Clinicians included anyone qual-
ified to prescribe antibiotics. We included reviews that included
trials from a variety of primary and ambulatory care settings. We
also included reviews with trials that recruited participants from
hospital inpatient settings, as well as primary or ambulatory care
settings, providing data from the latter were reported separately.
We defined primary care as any point-of-care in which patients are
managed at the first point of patient contact, and included general
practice, out-of-hours services, and emergency departments. We
excluded reviews solely in hospital inpatient settings and residen-
tial settings such as nursing homes, as these were not classed as
primary care settings. Patients could be any age, presenting with
an ARI, which was defined as any sudden-onset respiratory tract
infection.
Types of interventions
We included any intervention designed to change the antibiotic
prescribing behaviour of healthcare professionals for the manage-
ment of ARIs in primary care.We included the following interven-
tions: educational materials for clinicians, educational meetings,
educational outreach visits, audit and feedback, reminders, finan-
cial interventions, point-of-care tests, communication strategies,
mass media campaigns, delayed prescribing, or any other relevant
intervention. Interventions could target healthcare professionals
as a single population or as one of several groups. Interventions
could be compared to usual care or an alternative intervention.
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Types of outcome measures
Primary outcomes
1. Change in antibiotic prescriptions for ARI (total number
prescribed or proportion of patients prescribed antibiotics, to
include a delayed prescription, measured as absolute change or
relative percentage change).
Secondary outcomes
1. Prescribing outcomes:
i) proportion of patients with an ARI given an antibiotic
prescription for immediate use;
ii) proportion of patients with an ARI given a delayed
antibiotic prescription.
2. Patient outcomes:
i) proportion of patients with an ARI colonised or
infected with antibiotic-resistant bacteria;
ii) adverse events;
iii) symptom duration or severity;
iv) health-related quality of life;
v) patient satisfaction;
vi) any measure of management failure, e.g.
reconsultation for the same illness, hospital or emergency
department attendance.
3. Healthcare resource costs:
i) management costs for any medication for the
treatment of an ARI or associated complications.
Search methods for identification of reviews
Electronic searches
We searched the Cochrane Database of Systematic Reviews
(CDSR) and the Database of Abstracts of Reviews of Effects
(DARE). We searched five additional databases in order to iden-
tify any other relevant systematic reviews. We incorporated search
terms to target antibiotics, primary care settings, and ARIs but
did not include intervention-specific search terms. Information
Specialist Nia Roberts developed search strategies for all databases,
which are presented in Appendix 1. We applied no language re-
strictions to the searches. We searched the following databases:
• Cochrane Database of Systematic Reviews (Issue 6 of 12,
June 2016) and the Database of Abstracts of Reviews of Effects
(Issue 2 of 4, April 2015) in the Cochrane Library (searched 9
June 2016);
• Epub Ahead of Print, In-Process & Other Non-Indexed
Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)
(1946 to 9 June 2016);
• Embase OvidSP (1974 to 9 June 2016);
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature) EBSCO (1982 to 9 June 2016);
• PsycINFO (from 1967 to June Week 2 2016);
• Science Citation Index (Web of Science Core Collection)
(1945 to 9 June 2016).
We also ran a pre-publication, updated search on 19 May 2017,
screened the results, and placed relevant studies in ’Characteristics
of studies awaiting classification’ in Appendix 2. We will incorpo-
rate these in the next version of this review as appropriate.
Searching other resources
In addition to database searches, two overview authors (STC and
OvH) searched the reference lists of all included reviews.
Data collection and analysis
Selection of reviews
Two overview authors (STC and OvH) independently assessed
the titles and abstracts of reviews identified by the search strategy.
We excluded studies that were clearly not relevant. Both overview
authors independently screened the full texts of potentially eligible
reviews by applying the selection criteria. We agreed upon inclu-
sion of reviews by consensus and, if necessary, by discussion with
a third overview author (AMcC).
Data extraction and management
Two overview authors (STC and PST) independently extracted
data from the full texts using a standardised data extraction form.
The form included the following information:
1. general information (citation, author details, review ID);
2. aims and rationale;
3. extent of search (databases searched, restrictions);
4. eligibility criteria (types of studies included, whether RCTs
reported separately);
5. participants within reviews (number of patients, age,
primary care setting, indication for treatment);
6. interventions (type, target population);
7. comparator(s);
8. outcomes assessed; and
9. conclusions, recommendations, and limitations of the
review.
We extracted data on details of the intervention(s) and compari-
son, effect of the intervention relative to control, number of tri-
als and participants (patients), and quality of the evidence (us-
ing the Cochrane Handbook for Systematic Reviews of Interventions)
(Higgins 2011).
We resolved discrepancies by consensus or by discussion with a
third overview author (MPH).Where individual trials appeared in
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more than one included review, we noted the overlap and consid-
ered how trials had been interpreted by the author of each review.
Where there was complete overlap in trials included within two
or more reviews, two overview authors (STC and PST) discussed
which review should contribute to the overview, based on the out-
comes reported and risk of bias (Table 1).
Assessment of methodological quality of included
reviews
Quality of included reviews
Two overview authors (STC and PST) independently assessed
the methodological quality of each review using the ROBIS tool
(Whiting 2016). ROBIS is an up-to-date tool that provides a thor-
ough way of assessing risk of bias in reviews with a comprehensive
set of items on which to judge reviews. The ROBIS tool has three
phases, as follows.
Phase 1: Assessing relevance (optional)
This was not required, as the reviews had already been assessed for
relevance to the research question.
Phase 2: Identifying concerns with the review process
This consists of four domains against which a review is assessed:
1. study eligibility criteria;
2. identification and selection of studies;
3. data collection; and
4. study appraisal and synthesis and findings.
Each domain has five or six questions that are answered as ‘Yes’,
‘Probably Yes’, ‘Probably No’, ‘No’, and ‘No Information’. We
rated domains as ‘Low Risk’ if all questions were ‘Yes’ or ‘Probably
Yes’; ‘High Risk’ if they were ‘No’ or ‘Probably No’; and judged
the remainder as ‘Unclear’ (Whiting 2016).
Phase 3: Judging risk of bias
This summarises the concerns identified in Phase 2 and assesses
whether conclusions are supported by evidence by considering
three points:
1. interpretation of findings addresses all concerns identified
in Phase 2;
2. relevance of identified studies to the research question is
considered;
3. avoids emphasising results on basis of statistical significance.
We excluded reviews that were assessed as being at high risk of
bias based on Phase 2 and Phase 3 of the ROBIS assessment.
Some reviews scored high risk on only a few items. We considered
whether this influenced the overall result, and included reviews
where high risk of bias due to omissions in original review reporting
could be addressed in the overview.
We resolved differences in each overview author’s assessment of
quality by discussion. If we were unable to reach agreement, we
recorded this, and a third overview author (MPH) adjudicated.
Quality of evidence in included reviews
Risk of bias of individual trials
The review authors reported risk of bias of trials in reviews. The
overview authors extracted and summarised the data.
GRADE assessments for each comparison/outcome
Two overview authors (STC and PST) examined the included re-
views for information on the quality of the trials within each re-
view, and where described, extracted it for each outcome. Where
this information was not provided, we used the GRADE tool to
make a retrospective assessment (Guyatt 2008; Higgins 2011).We
used the five GRADE considerations (study limitations, consis-
tency of effect, imprecision, indirectness, and publication bias) to
assess the quality of evidence of the trials contributing data for
each outcome.
Data synthesis
We produced a narrative summary of all the results reported in
the included systematic reviews and presented a summary of data
using an ’Overview of reviews’ table, which provides details of
reviews based on all relevant outcomes.
We planned to perform subgroup analysis using Review Manager
5 software, data permitting, for the following (RevMan 2014);
1. adults (aged ≥ 18 years) versus children;
2. placebo versus no intervention; and
3. combined interventions versus single intervention.
Data were not available to undertake the planned subgroup anal-
ysis or sensitivity analysis.
R E S U L T S
We searched the databases in June 2016. Figure 1 shows the re-
views identified at each stage of the search process. Our database
searches identified 910 records, of which 314 were duplicates.
We identified four additional papers from searching the references
of included reviews. Of the 600 records, we excluded 577 after
screening titles and abstracts. We assessed the full texts of the re-
maining 23 reviews, and excluded another 12. This left 11 reviews
for potential inclusion. We excluded an additional three reviews
following the ROBIS assessment (Table 2; Appendix 3).
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Figure 1. Study flow diagram.
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We re-ran the search in May 2017, identifying a total of 96 new
references. We selected a further three reviews for in-depth assess-
ment (Hu 2016; McDonagh 2016; O’Sullivan 2016). We also
identified a systematic review protocol published in June 2017
that would likely meet our inclusion criteria once completed
(Martinez-Gonzalez 2017). We added these four potential new
reviews of interest to a list of ‘Characteristics of studies awaiting
classification’, and we will incorporate them into overview find-
ings during the next update (Appendix 2).
Description of included reviews
A summary of the included reviews can be found in Table 3. A
list of reviews, interventions, and trials that contributed to the
overview is presented in Table 1.
Two reviews focussed specifically on interventions used in emer-
gency departments, whilst the remainder focussed on general prac-
tice or family practice depending on the countries included.Nearly
all trials were undertaken in high-income countries, in particular
Europe and North America, with the remainder in China. Both
trials fromChina focussed on the use of procalcitonin-guided ther-
apy in the emergency department.Most reviews and their included
trials were conducted in the last 10 years; the oldest review was
dated 2005, and the oldest trial 1995. The majority of trials were
carried out between 2003 and 2010.
Some trials were reported inmore than one review (Table 1). Trials
byCals and colleagues, Cals 2009, Cals 2010, Cals 2013, appeared
in two or more reviews (Aabenhus 2014; Coxeter 2015; Huang
2013). Little 2013 also appeared in Aabenhus 2014 and Coxeter
2015. Cals 2009 and Little 2013 both tested the effectiveness of
two types of intervention on antibiotic prescribing: CRP testing
and communication skills training for the clinician. As such, results
about the effectiveness of different trial arms appear in reviews
on CRP and on shared decision making. Due to the overlap in
trials between Aabenhus 2014 and Huang 2013, only the three
additional trials reported in Huang 2013 are discussed in addition
to the results of Aabenhus 2014. The trial by Francis 2009 appears
both in de Bont 2015 and Coxeter 2015, which consider the use
of patient information leaflets by clinicians and shared decision
making. The interactive aspect of the intervention by Francis
2009 is discussed, and its novelty in comparison to other patient
information leaflets which are not used interactively is noted.
Point-of-care tests
Four of the eight included reviews assessed the use of a POCT
as an intervention to change clinician antibiotic prescribing. Two
assessed CRP testing, most often used as a near patient test which
provided a result within minutes. One assessed rapid viral diag-
nostic testing in the emergency department (ED), where results
were available during a patient’s stay in the ED (within hours).
Another assessed procalcitonin-guidedmanagement, where results
were also available within hours.
Aabenhus 2014 searched six databases up to January 2014 and
included six trials, all of which tested the effectiveness of CRP
point-of-care testing on antibiotic prescribing for ARIs. The trials
included 3284 participants; five trials included only adults (older
than 17 years), and one trial included both adults and children (
Diederichsen 2000). All trials were carried out in European general
practice. The trials included three RCTs and three cluster-RCTs.
Huang 2013 searched two databases and included 13 studies,
seven RCTs and six observational studies, to explore the effective-
ness of CRP testing in the management of respiratory tract in-
fections (RTIs) in general practice. We extracted only data from
randomised trials for this overview: four were RCTs and three
were cluster-RCTs. All trials were carried out in European general
practice, except for one carried out in the USA (Gonzales 2011).
The trials included a total of 2570 participants; six of the trials
included adults only, and one included both adults and children
(Diederichsen 2000).
Four trials assessed CRP testing and were identified by both
Aabenhus 2014 and Huang 2013.
Four trials, of which three were RCTs (one quasi-RCT was not
included), assessed rapid viral diagnostics in the management of
children (aged less than 18 years) with ARI in the emergency
department: Bonner 2003 recruited patients aged 2 to 21 years
who presented to an ED in the USA with fever and ARI (n = 391);
Poehling 2006 recruited patients age less than 5 years presenting
with RTI in a US ED (~20% of patients were at high risk from
asthma; 5% had a pre-diagnosis that required exclusion from the
analysis (n = 300)); Doan 2009 recruited patients aged 3 to 36
months presenting in an ED in Canada with febrile ARI (n = 200).
Schuetz 2012 searched three databases up to May 2011 and in-
cluded 14 RCTs assessing procalcitonin in EDs, hospital wards,
and intensive care units. We extracted data for nine of the 14 trials
undertaken in outpatient settings, and included 3613 adult pa-
tients aged ≥ 18 years. Two trials were undertaken with patients
with ARI in general practice in Switzerland and Germany (Briel
2008; Burkhardt 2010); the remaining seven took place in the
ED. Of the seven which took place in the ED, four trials were
conducted in Switzerland (Christ-Crain 2004; Christ-Crain 2006;
Schuetz 2009; Stolz 2007), two inChina (Long 2009; Long 2011),
and one inDenmark (Kristoffersen 2009). Three included partici-
pants with lower respiratory tract infections (LRTIs) (some studies
with X-ray confirmation) (Christ-Crain 2004; Kristoffersen 2009;
Schuetz 2009); three included participants with community-ac-
quired pneumonia (CAP), with some participants undergoing X-
ray confirmation (Christ-Crain 2006; Long 2009; Long 2011);
and one included participants with COPD exacerbation (Stolz
2007).
Doan 2014 and Schuetz 2012 both included trials that recruited
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patients with chronic and more serious ARIs or complications
(CAP, asthma, and COPD). However, we assumed that these tri-
als focussed on ARIs because their aim was to reduce antibiotic
prescribing, therefore we included them in this overview.
Communication strategies
Shared decision making
Coxeter 2015 searched four databases up to December 2014 and
included 10 reports of nine original RCTs. All trials explored the
effect of interventions that aim to facilitate shared decision mak-
ing (SDM) on antibiotic prescribing for ARIs in primary care. In-
terventions were included if they explicitly stated that they incor-
porated SDM, or if the intervention included one of the elements
of SDM described by Makoul 2006. The trials included a total of
490,083 participants; all trials were carried out in European gen-
eral practice, except for two trials conducted in Canada (Légaré
2011; Légaré 2012); all trials were cluster-RCTs with the unit of
randomisation as the individual general practitioner or practice
group; four trials included patients of any age, while four included
only adults, and one only children. Trials included patients with
ARI, LRTI (and upper respiratory tract infection (URTI)), and
acute cough.
Patient information leaflets used by clinicians in
consultations
de Bont 2015 searched two databases up to April 2014 and in-
cluded eight studies (seven RCTs, one non-RCT) assessing the ef-
fect of patient information leaflets on antibiotic use and reconsul-
tation; two trials undertaken in UK general practice were relevant
because they measured clinician antibiotic prescribing: Francis
2009 tested the effectiveness of an interactive patient booklet on
management of children with acute RTI (n = 558); Macfarlane
1997 tested the effectiveness of a patient information leaflet on
management of adults (aged more than 15 years) with acute LRTI
(n = 1014).
Educational materials for clinician and reminders
Boonacker 2010 searched three databases up to February 2009
and included 10 studies, all of which assessed interventions to pro-
mote evidence-based practice for themanagement of childrenwith
URTI, which we regarded as largely synonymous with ARIs. The
review included RCTs, non-RCTs, and controlled before-and-af-
ter studies. Two RCTs were relevant to this overview: Christakis
2001 assessed a computerised decision support system on clini-
cians’ management of acute otitis media in a paediatric practice
in the USA; Wilson 2002 studied the effect of collaborative de-
velopment of guidelines and educational materials on clinicians’
management of children aged less than 2 years with ARI in general
practice in Australia. In both trials the intervention was targeted
at individual clinicians, and patient numbers were not reported.
Multifaceted interventions (multiple interventions used
within one approach)
Arnold 2005 searched three databases up to May 2000 and De-
cember 2002 and included 39 studies assessing professional inter-
ventions, as defined by the Cochrane Effective Practice and Or-
ganisation of Care Group (EPOC), to improve the selection, dose,
and duration of antibiotics prescribed in the outpatient setting.
The review included RCTs, non-RCTs, interrupted time series
analysis, and controlled before-and-after studies. Five RCTs were
relevant to this overview: three included only children (Finkelstein
2001; Flottorp 2002; Mainous 2000), and two included patients
agedmore than 15 years or agedmore than 3 years (McIsaac 1998;
McIsaac 2002). Two trials were undertaken in primary care set-
tings in the USA (Finkelstein 2001;Mainous 2000), two in family
practice in Canada (McIsaac 1998; McIsaac 2002), and one in
general practice in Norway (Flottorp 2002). Both Canadian trials
included interventions with printed educational materials for the
clinician and reminders (McIsaac 1998; McIsaac 2002). Mainous
2000 included patient educational materials and audit and feed-
back for the clinician. Flottorp 2002 included clinician educa-
tional materials, reminders, patient educationmaterials, computer
decision support, and opportunities to gain continuedprofessional
development credit, and increased the price of telephone consul-
tations. Finkelstein 2001 included clinician educational materials,
audit and feedback, patient educational materials, and input from
local opinion leaders. The number of patients seen within trials
was not reported.
Methodological quality of included reviews
Quality of included reviews
Three reviews (all Cochrane Reviews) scored low risk across all
of the ROBIS domains in Phase 2 and low risk of bias overall
(Aabenhus 2014; Doan 2014; Schuetz 2012). The remaining five
reviews scored high risk on Domain 4 of Phase 2, specifically
on point 4.6 (whether biases in primary studies were minimal or
addressed in the synthesis, because the ’Risk of bias’ assessment
had not been specifically considered and discussed in the review
Results and Conclusions) (Table 1) (Arnold 2005; Boonacker
2010; Coxeter 2015; de Bont 2015; Huang 2013).
Quality of evidence in included reviews
Risk of bias of individual trials
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Review authors assessed the risk of bias of trials within reviews
using the Cochrane ’Risk of bias’ tool (Higgins 2011); the re-
sults are presented in Table 4. One review used EPOC criteria in-
stead, which is available on the EPOCwebsite as “suggested risk of
bias criteria” (epoc.cochrane.org/epoc-specific-resources-review-
authors) (Arnold 2005). Thismostly replicated theCochrane ’Risk
of bias’ tool, except that it did not assess random sequence gener-
ation, blinding of participants, or selective reporting of data.
Trials within reviews were generally scored as at low risk of bias
on random sequence generation, incomplete outcome data, and
selective reporting. Allocation concealment and blinding of out-
come assessment were more often judged to be at unclear or high
risk of bias, and blinding of participants was infrequently reported
due to the nature of the interventions being delivered, and was
thus judged as at high risk of bias. Review authors did not often
report risk of other bias, or they reported that information from
individual trials was unclear. Aabenhus 2014 and Huang 2013
included four trials that appeared in both reviews. However, the
’Risk of bias’ assessment reported in each review was distinctly dif-
ferent for random sequence generation and blinding of outcome
assessment. Additional information about ’Risk of bias’ assessment
in Huang 2013 was not available. However, Aabenhus 2014 (a
Cochrane Review) provided more detail and assessed the risk of
bias for each trial.
GRADE assessments for each comparison/outcome
Only three included reviews (all Cochrane Reviews) used GRADE
criteria to summarise the quality of evidence for each of their out-
comes (Table 5) (Aabenhus 2014; Coxeter 2015; Schuetz 2012).
Aabenhus 2014 reported that evidence for the effect of CRP test-
ing on four outcomes was of moderate quality as assessed by the
GRADE criteria. Evidence was downgraded primarily based on
imprecision of the estimated effect. Coxeter 2015 and Schuetz
2012 reported that the evidence for the effect of shared decision-
making interventions and procalcitonin-guided management on
antibiotic prescribing was also of moderate quality. Evidence was
downgraded primarily due to high risk of bias in included trials.
WeusedGRADE to summarise the quality of the evidence for each
type of intervention and each primary outcome for the remaining
reviews (Table 5) (Guyatt 2008; Higgins 2011). We assessed the
quality of evidence for outcomes reported by Doan 2014 as low,
downgrading because of high risk of bias in included trials due to
lack of allocation concealment and lack of blinding of participants,
and due to imprecision as a result of wide confidence intervals. We
assessed three of the trials reported in Huang 2013 individually
due to overlap with Aabenhus 2014.We assessed two trials, under-
taken in general practice, to be of moderate quality, downgrading
because of high risk of bias due to inadequate methods of sequence
generation, lack of allocation concealment, and lack of blinding
of participants. We downgraded the third trial, carried out in the
ED, because of high risk of bias and imprecision as a result of
wide confidence intervals and small sample size. We assessed the
quality of evidence for outcomes reported by Boonacker 2010 as
very low, downgrading because of high risk of bias in included tri-
als, reported publication bias, and imprecision due to sample size
not being reported. We assessed the quality of evidence for out-
comes reported by de Bont 2015 and Arnold 2005 as low or very
low, downgrading because of high risk of bias in included trials,
inconsistency in results, and imprecision due to wide confidence
intervals and sample size not being reported (Table 5).
Effect of interventions
A summary of results is presented in Table 5.
Subgroup analyses were not possible due to the heterogeneity of
included reviews and the data available.
Change in antibiotic prescriptions for ARI
Point-of-care tests
CRP testing
Aabenhus 2014 andHuang 2013 both presentedmoderate-quality
evidence that CRP testing probably reduces antibiotic prescribing
in general practice compared to usual care.
Aabenhus 2014 found an overall effect of CRP testing showing
that antibiotic prescribing is probably decreased at the initial con-
sultation: risk ratio (RR) 0.78, 95% confidence interval (CI) 0.66
to 0.92, 3284 participants, 6 trials, moderate-quality evidence).
Aabenhus 2014 reported that the effect ofCRP testing onprescrib-
ing is probably maintained at 28 days postconsultation, meaning
that patients did not receive a prescription from the same practice
at a later date (RR 0.80, 95% CI 0.67 to 0.96, 3284 participants,
6 trials, moderate-quality evidence).
Huang 2013 reported seven trials that investigated the effects of
CRP testing in both general practice and EDs. We have reported
the three trials that were not included in the review by Aabenhus
2014. Two trials in general practice showed that CRP testing prob-
ably led to a decrease in antibiotic prescriptions compared to usual
care (Cals 2011 (RR 0.57, 95%CI 0.44 to 0.74; 330 participants)
and Cals 2013 (RR 0.58, 95% CI 0.45 to 0.74; 379 participants)
(moderate-quality evidence)).
Huang 2013 presented low-quality evidence from a single small
trial showing that CRP testing may have little or no effect on an-
tibiotic prescribing in EDs compared to usual care (RR 1.23, 95%
CI 0.76 to 1.99, 131 participants, 1 trial, low-quality evidence)
(Gonzales 2011).
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Rapid viral diagnostics
Doan 2014 found that rapid viral diagnostics may have little or
no effect on antibiotic prescribing in the ED compared to usual
care (RR 0.86, 95% CI 0.61 to 1.22, 891 participants, 3 trials,
low-quality evidence).
Procalcitonin-guided management
Schuetz 2012 reported the effect of procalcitonin measurement on
the initiation of antibiotics and found that it probably decreased
antibiotic initiation in both general practice (adjusted odds ra-
tio (OR) 0.10, 95% CI 0.07 to 0.14, 1008 participants, 2 trials,
moderate-quality evidence) and the ED (adjusted OR 0.34, 95%
CI 0.28 to 0.43, 2605 participants, 7 trials, moderate-quality ev-
idence) compared to usual care.
Shared decision making
Coxeter 2015 reported moderate-quality evidence showing that
shared decision making probably reduces antibiotic prescribing
compared to usual care. They pooled the results of trials using three
sets of adjusted effect estimates as part of a sensitivity analysis: set
one (OR 0.44, 95% CI 0.26 to 0.75, 3274 participants, 3 trials);
set two (recalculating the adjusted RR) (RR 0.64, 95% CI 0.49
to 0.84, 4623 participants, 2 trials); and set three (risk difference
(RD) -18.44, 95% CI -27.24 to -9.65, 481,807 participants, 4
trials). This overview reports only these analyses from Coxeter
2015, which examined the effect of shared decision making on
antibiotic prescribing by the clinician. Other analyses focussed
on “antibiotics prescribed, dispense or decision to use” were not
extracted as these included assessing the effect of shared decision
making on patient behaviour.
Patient information leaflets used by clinicians in
consultations
de Bont 2015 reported very low-quality evidence from two trials
assessing the effectiveness of patient information leaflets on the
antibiotic prescribing of general practitioners, one showing a sub-
sequent reduction in prescribing (RR 0.47, 95% CI 0.36 to 0.64,
558 participants) (Francis 2009), and one showing no evidence
of an effect (RR 1.15, 95% CI 0.89 to 1.48, 1014 participants)
(Macfarlane 1997). We are therefore uncertain about whether pa-
tient information leaftlets reduce antibiotic prescribing compared
to usual care.
Educational materials for clinicians and reminders
Boonacker 2010 reported very low-quality evidence from two tri-
als on the effect of computerised decision support on antibiotic
prescribing (Christakis 2001; Wilson 2002), therefore we are un-
certain as to whether this has an effect compared to usual care.
One of the included trials, Christakis 2001, presented evidence
of an increase in antibiotic prescribing by both the intervention
and control groups, but suggested that the intervention had a pre-
ventive effect by avoiding further increases in the rate of antibi-
otic prescribing (RD -12%, CI not reported, P = 0.095, partic-
ipant number not reported). The second included trial, Wilson
2002, reported evidence that collaborative development of guide-
lines and education materials resulted in a reduction in antibiotic
prescribing for ARI episodes (adjusted OR 0.60, 95% CI 0.43 to
0.83, participant number not reported).
Multifaceted interventions (multiple interventions used
within one approach)
Arnold 2005 reported five trials using multifaceted interventions
(Finkelstein 2001; Flottorp 2002; Mainous 2000; McIsaac 1998;
McIsaac 2002).
McIsaac 1998 and McIsaac 2002 reported very low-quality evi-
dence on the effect of printed educational materials for clinicians
with or without reminders compared to usual care, meaning that
we are uncertain about their effects on antibiotic prescribing com-
pared to usual care. One trial found reduced antibiotic prescrib-
ing (OR 0.44, 95% CI 0.21 to 0.92, participant number not re-
ported) (McIsaac 1998), while the other showed no effect (OR
0.57, 95% CI 0.27 to 1.17, participant number not reported)
(McIsaac 2002).
Mainous 2000 reported low-quality evidence that audit and feed-
back alone or with patient education materials may reduce clini-
cians’ antibiotic prescribing compared to usual care. They reported
an increase in antibiotic prescribing for all groups, although groups
that received patient education materials (with or without audit
and feedback) prescribed significantly fewer antibiotics than the
control (T = 2.374, P < 0.05 (exact P value not given), participant
number not reported).
Finkelstein 2001 presented low-quality evidence that educational
materials and educational meetings for clinicians with patient ed-
ucation materials may reduce antibiotic prescribing compared to
usual care in populations aged 3 to 36 months (16%, 8% to 23%)
and 36 to 72 months (12%, 2% to 21%) (participant numbers
not reported).
Flottorp 2002 also presented low-quality evidence that a mul-
tifaceted intervention containing five component interventions
may slightly reduce antibiotic prescribing compared to usual care
(-3.0% compared with control, P = 0.03, participant number not
reported). The intervention included education materials for the
clinician, computerised decision support, professional develop-
ment, financial incentives, and patient education materials.
Proportion of patients with an ARI given an antibiotic
prescription for immediate use and proportion of
patients with an ARI given a delayed antibiotic
prescription
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None of the trials in the included reviews reported the proportion
of patients who were provided with antibiotic prescriptions for
immediate or delayed use.
Proportion of patients with an ARI colonised or
infected with antibiotic-resistant bacteria
None of the trials in the included reviews reported the proportion
of patients colonised or infected with antibiotic-resistant bacteria.
Adverse events
Only two of the eight reviews reported on adverse events.
Aabenhus 2014 reported moderate-quality evidence that CRP
point-of-care testing probably results in little or no difference in
adverse events compared to usual care. One of the trials in this
review, Little 2013, found evidence of increased hospitalisation in
patients for the trial arm using the CRP test (crude RR 2.53, 95%
CI 1.13 to 5.66), although after adjusting for the trial’s cluster
design, the difference was not significant (RR 2.45, 95% CI 0.65
to 9.19, 4264 participants, moderate-quality evidence). Aabenhus
2014 reported no deaths in any of the six trials evaluating CRP
testing.
Coxeter 2015 reported that six of the nine trials evaluating shared
decision making reported serious adverse events requiring hospi-
talisation, but the review authors reported that there was no differ-
ence between intervention and control groups. One trial reported
a death due to myocardial infarction following pneumonia for an
elderly patient in the control arm of the trial (Briel 2006). No
trials reported on all-cause mortality.
Symptom duration or severity
Aabenhus 2014 was the only review to report on symptom du-
ration or severity, from three trials evaluating CRP testing (either
as a median symptom duration to full recovery, or resolution of
symptoms rated moderately bad or worse) (Cals 2009; Cals 2010;
Little 2013). The review authors presented moderate-quality evi-
dence that CRP point-of-care testing probably results in little or
no difference in symptom duration or severity compared to usual
care at seven days (RR 1.03, 95% CI 0.93 to 1.14, 1309 partici-
pants, 3 trials) or at 28 days (RR 0.94, 95% CI 0.69 to 1.28, 849
participants, 3 trials).
Health-related quality of life
Schuetz 2012 was the only review to report on health-related qual-
ity of life of participants taking part in a trial of procalcitonin on
prescribing, findingmoderate-quality evidence that procalcitonin-
guided management probably results in little or no difference in
days of restricted activities after 14 days (adjusted difference in
days 0.05, 95% CI -0.46 to 0.56, P = 0.854, 1008 participants, 2
trials, moderate-quality evidence).
Patient satisfaction
Three reviews reported on patient satisfaction. Aabenhus 2014
and Huang 2013 reported the same two trials evaluating CRP
testing (Cals 2009; Cals 2010), finding moderate-quality evidence
that CRP point-of-care testing probably results in little or no dif-
ference in patient satisfaction compared to usual care (RR 0.79,
95% CI 0.57 to 1.08, 689 participants, 2 trials, moderate-quality
evidence). Coxeter 2015 reported patient satisfaction for two trials
evaluating shared decision making, finding that shared decision
making may result in little or no difference in patient satisfaction
compared to usual care (RR 0.86, 95% CI 0.57 to 1.30, 1110
participants, 2 trials, low-quality evidence).
Management failure
This outcome was most often reported as reconsultation for the
same illness episode. Aabenhus 2014 found CRP point-of-care
testing probably results in little or no difference in reconsultation
compared with usual care at 28 days’ follow-up (RR 1.08, 95%
CI 0.93 to 1.27, 5132 participants, 4 trials, moderate-quality ev-
idence). Likewise, Coxeter 2015 found that shared decision mak-
ing probably results in little or no difference in reconsultation for
the same illness compared to usual care (RR 0.87, 95% CI 0.74
to 1.03, 1860 participants, 4 trials, moderate-quality evidence).
de Bont 2015 reported very low-quality evidence from two tri-
als that measured reconsultations for interventions with patient
information leaflets. One trial showed evidence of a reduction in
reconsultation in patients who had received the intervention (RR
0.70, 95%CI 0.53 to 0.91, 1014 participants) (Macfarlane 1997);
however, the second trial showed no evidence of an effect (RR
0.80, 95% CI 0.52 to 1.21, 558 participants). We are therefore
uncertain about the effect of patient intervention leaflets on re-
consultation compared to usual care (Francis 2009). Doan 2014
reported low-quality evidence from one trial on the effect of rapid
viral diagnosis on doctors’ visits within two weeks of discharge
following patients’ visits to the ED. The review authors found that
testing may have little to no effect on reconsultation compared to
usual care (RR 0.86, 95% CI 0.59 to 1.25, 200 participants, 1
trial, low-quality evidence) (Doan 2009).
Schuetz 2012 found moderate-quality evidence that procalci-
tonin-guided management probably results in little or no differ-
ence in treatment failure in general practice compared to nor-
mal care (adjusted OR 0.95, 95% CI 0.73 to 1.24, 1008 partic-
ipants, 2 trials, moderate-quality evidence). For patients seen in
the ED, there was moderate-quality evidence that procalcitonin-
guided management probably reduces treatment failure in the ED
compared to usual care (adjusted OR 0.76, 95% CI 0.61 to 0.95,
2605 participants, 7 trials, moderate-quality evidence).
Management costs for any medication for the
treatment of an ARI or associated complications
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None of the trials in the included reviews reported onmanagement
costs for the treatment of an ARI or any associated complications.
D I S C U S S I O N
Summary of main results
This overview identified eight reviews assessing clinician-focussed
interventions to influence antibiotic prescribing for ARIs in pri-
mary care. There was moderate-quality evidence indicating that
point-of-care CRP testing (two reviews, nine trials), procalcitonin-
guided management (one review, nine trials), and shared decision
making (one review, nine trials) probably safely reduce antibiotic
prescribing in the management of ARIs compared to usual care.
The overall effect of these interventions was small (few achieving
greater than 50% reduction in antibiotic prescribing, most about
a quarter or less), but is likely to be clinically important. The inter-
ventions we have reported likely influence different mechanisms
of behaviour change, so it is possible that combining interventions
will result in greater effects.
For the other interventions, including multifaceted interventions,
those centred on clinician education, patient information leaflets,
and the use of rapid viral diagnostics, the evidence was of low or
very low quality across outcomes, and we could not confidently
draw any conclusions about the effects of these interventions com-
pared to usual care. Further primary research is necessary to im-
prove the evidence base in order to be able to make informed de-
cisions about the value of these interventions.
None of the trials in the included reviews reported onmanagement
costs for the treatment of an ARI or any associated complications.
Overall completeness and applicability of
evidence
The inclusion of both Cochrane and non-Cochrane reviews pro-
vides a comprehensive summary of all eligible systematic reviews.
The reviews reported on a wide range of interventions, although
for each intervention there were few reviews. Most reviews ad-
dressed the effects of diagnostic tests on antibiotic prescribing.
One of the included reviews investigated multifaceted interven-
tions containing multiple components, including clinician and
patient education, audit and feedback, and reminders. Since no
review studied these interventions alone, the separate effects of
each are unknown.
The descriptions of point-of-care diagnostics and shared decision
making interventions were detailed enough to enable replication
in clinical practice. The use of CRP testing and shared decision
making in general practice was explored frequently in trials and re-
views, and there appears to be sufficient evidence for policymakers
and clinicians to decide whether these interventions would be use-
ful in their own contexts. However, sufficient detail for replication
was lacking for the other intervention types under the categories of
clinician education, patient information leaflets, and reminders.
This was reflected in the original trials. Similarly, ‘usual care’ - the
control arm of most trials - was also poorly described.
There is a risk that in categorising interventions in the way that we
did for this overview, we inadvertently grouped those with differ-
ent underlying mechanisms of behaviour change. For example, of
the two trials of patient information leaflets, effectiveness was only
demonstrated when the leaflet was used “interactively” as part of
the intervention. Future investigators of trials and reviews should
describe interventions more comprehensively. Other review au-
thors have further considered and classified the different compo-
nents of interventions categorised in this way (Davey 2017).
It is possible that a combination of intervention types would have
an additive (or even multiplicative) effect because they probably
act with quite separate mechanisms of action (notwithstanding
the unknown nature of these). However, ideally these should be
tested separately as well as in combination.
Few trials compared interventions against one another, so we had
no data to assess the relative performance of different interven-
tions.
Although our search identified reviews of delayed-prescribing in-
terventions, none measured antibiotic prescribing behaviour as an
outcome, which focusses on both clinicians (to change their be-
haviour to writing delayed, rather than immediate, prescriptions,
and provide accompanying advice to patients) as well as patient
behaviour (by giving them responsibility about whether or when
they access antibiotics). The trials randomised patients to imme-
diate, delayed, or no-prescription arms, and since consumption of
antibiotics was the most common primary outcome, there was no
measure of only the clinicians’ behaviour.
Three of our prespecified outcomes were not reported in the con-
tributing reviews. These outcomes were the proportion of patients
receiving an antibiotic prescription for immediate or delayed use,
the proportion of patients with an ARI colonised or infected with
antibiotic-resistant bacteria, and themanagement cost of anymed-
ication to treat an ARI or any associated complications. Delayed
prescriptions are often not easily identifiable in general practice
records, as they most often reflect a change in the verbal instruc-
tions given to a patient rather than a change in the issuing of the
prescription; as such, it is a difficult outcome for trials to measure.
Similarly, identifying antibiotic-resistant bacteria requires lab sam-
ples, which adds complexity and cost to an RCT. The cost-effec-
tiveness of interventions in this area is not commonly examined,
and further research in this field is needed.
Most of the trials in the included reviews were undertaken in high-
income countries, in particular countries in Europe and North
America, and their findingsmay not be applicable in other settings.
14Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an
overview of systematic reviews (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Quality of the evidence
The reviews included in this overview were conducted to a high
standard, although five of the eight reviews were marked down on
one ROBIS domain because potential biases in primary studies
were not considered in the interpretation of findings or in the dis-
cussion. The three reviews that scored low risk on all four ROBIS
domains were all Cochrane Reviews, although a further Cochrane
Review was also marked down on domain 4 of ROBIS, as were
the non-Cochrane reviews (Table 1).
The quality of evidence in included reviews was rated according
to the GRADE criteria. The quality varied, with no outcomes
rated as having high-quality evidence in any included review. The
most common reason for downgrading quality of evidence for each
outcome was when there was judged to be a high risk of bias in
the relevant trials and/or when there was imprecision in the main
effect. The unavoidable lack of blinding of participants increased
the risk of bias in trials. However, blinding of outcome assessment
and allocation concealment was also generally not reported, which
increased the risk of bias, particularly for trials investigating the
effect of POCTs used by clinicians.
For the reviews in which the quality of evidence for outcomes
was rated as low, evidence was downgraded by one level when
there was judged to be high risk of bias, and a second level due
to inconsistency in results, imprecision, or reported publication
bias. Where evidence was rated as very low, evidence was down-
graded another level due to imprecision in the effect estimate. The
GRADE ratings for each outcome in each review are presented
in Table 5, along with footnotes describing the rationale for each
downgrading decision.
Potential biases in the overview process
Our methods of independent assessment of bias and data extrac-
tion (with arbitration by a third overview author) should have
reduced the risk of bias in generating this overview. However,
we could not formally assess the risk of publication bias in this
overview because there were too few reviews, nor was this assessed
in the included reviews. If studies that were narrative reviews (i.e.
without quantification of the results) were more likely to be neg-
ative, our exclusion of them might have introduced publication
bias.
Where reviews did not report quality of evidence according to
GRADE criteria, we applied this retrospectively. This approach
was limited as it used ’Risk of bias’ assessments made by the review
authors, and the depth of reporting between reviews varied.When
reviews did report quality of evidence according to GRADE cri-
teria, we reported the findings of the review authors.
Some overview authors are also authors on included reviews, which
had the potential to introduce bias when presenting the results.
However, the data extraction, narrative summary, and reporting
of the overview was led by three overview authors who had no
connection to previous reviews in order to minimise any bias.
Agreements and disagreements with other
studies or reviews
We excluded many reviews because they did not meet our inclu-
sion criteria. However, we are not aware of any other quantitative
published overviews of reviews of clinician-targeted interventions
to reduce antibiotic prescribing for acute ARIs.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found insufficient evidence to identify which types of inter-
vention or intervention components are most effective at influ-
encing antibiotic prescribing behaviour for acute respiratory in-
fection (ARI) in primary care. Moderate-quality evidence suggests
that the following interventions likely have an important effect on
reducing antibiotic prescribing:
• C-reactive protein point-of-care testing in general practice
to reduce antibiotic prescribing with no differences in symptom
duration, patient satisfaction, or reconsultation;
• shared decision making in the management of ARI in
general practice to reduce antibiotic prescribing whilst
maintaining patient satisfaction and without increasing
likelihood of reconsultation;
• procalcitonin-guided management of ARI in general
practice and emergency departments to reduce antibiotic
prescribing without affecting health-related quality of life and
whilst avoiding treatment failure.
Clinicians and health policy makers should note that most of
this research was undertaken in high-income countries, and may
therefore not be applicable elsewhere. No information on man-
agement costs was reported, and therefore no conclusions could
be made about cost-effectiveness of interventions. It is likely that
cost-effectiveness information would help policymakers and clin-
icians choose between point-of-care tests for use in their own con-
texts. Shared decision-making interventions could provide clini-
cians with skills that can be used outside of respiratory tract in-
fection consultations, which policymakers and clinicians may also
want to consider when thinking about value for money.
For the other interventions, including multifaceted interventions,
those centred on clinician education, patient information leaflets,
and the use of rapid viral diagnostics, the evidence was of low or
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very low quality across outcomes, therefore we could not confi-
dently draw conclusions about the effects of these interventions.
Further primary research is necessary to improve the evidence base
in order to be able to make informed decisions about the value of
these interventions.
Implications for research
There is a clear need for further primary research in this area.
More high-quality trials that strive to minimise risk of bias in their
conduct and fully report their methods are required. Better inves-
tigation of the effects of interventions between different settings
(differences between primary care and emergency departments,
for example) is also needed. Qualitative research can be used to
further understand clinicians’ behaviours and how they use inter-
ventions in everyday practice.
There was a paucity of measurement of secondary outcomes such
as prescribing rates and patient outcomes, particularly symptoms
and antibiotic resistance, and healthcare resources such as cost-
effectiveness. These are important outcomes in order to weigh the
benefits and costs of interventions, and should be measured in
future trials.
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A D D I T I O N A L T A B L E S
Table 1. List of reviews, interventions, and trials that contributed to the overview with ROBIS assessment
Intervention Review RCTs con-
tributed and
sample size
(n)
ROBIS assessment
Phase 2 domains Phase 3
1. Study eligi-
bility criteria
2. Identifica-
tion
and selection
of studies
3. Data col-
lection
and study ap-
praisal
4. Synthesis
and findings
5.Risk of bias
of review
POCT: C-re-
active protein
Aabenhus
2014
Andreeva
2014 (179)
Cals 2009
(431)
Cals 2010
(258)
Diederichsen
2000 (812)
Little 2013
(4264)
Melbye 1995
(239)
Low risk Low risk Low risk Low risk Low risk
Huang 2013 Cals 2009
(431)
Cals 2010
(258)
Cals 2011
(330)
Cals 2013*
(379)
Diederichsen
2000 (812)
Gonzales
2011 (131)
Melbye 1995
(229)
Low risk Low risk Low risk High risk Low risk
POCT: rapid
viral detection
test
Doan 2014 Bonner 2003
(391)
Doan 2009
(200)
Poehling 2006
(300)
Low risk Low risk Low risk Low risk Low risk
POCT:
procalcitonin
Schuetz 2012 Briel 2008
(458)
Burkhardt
Low risk Low risk Low risk Low risk Low risk
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Table 1. List of reviews, interventions, and trials that contributed to the overview with ROBIS assessment (Continued)
2010 (550)
Christ-Crain
2004 (243)
Christ-Crain
2006 (302)
Kristoffersen
2009 (210)
Long 2009
(127)
Long 2011
(156)
Schuetz 2009
(1359)
Stolz 2007
(208)
Ed-
ucational ma-
terials for clin-
ician or deci-
sion support,
or both
Boonacker
2010
Christakis
2001 (NR)
Wilson 2002
(NR)
Low risk Low risk Low risk High risk Low risk
Interven-
tions to sup-
port shared
decision mak-
ing
Coxeter 2015 Altiner 2007
(2164)
Briel 2006
(552)
Butler 2012
(479,502)
Cals 2009
(431)
Cals 2013*
(379)
Francis 2009
(558)
Légaré 2011
(151)
Légaré 2012
(359)
Little 2013
(4264)
Welschen
2004 (1723)
Low risk Low risk Low risk High risk Low risk
Patient infor-
mation leaflets
to be used by
clinician
de Bont 2015 Francis 2009
(558)
Macfarlane
1997 (1014)
Low risk Low risk Low risk High risk Low risk
22Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an
overview of systematic reviews (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. List of reviews, interventions, and trials that contributed to the overview with ROBIS assessment (Continued)
Multifaceted
interventions
Arnold 2005 Finkelstein
2001 (NR)
Flottorp 2002
(NR)
McIsaac 1998
(NR)
McIsaac 2002
(NR)
Mainous 2000
(NR)
Low risk Low risk Low risk High risk Low risk
*Cals 2013 is a follow-up study of the trial reported in Cals 2009.
NR: not reported
POCT: point-of-care-test
RCT: randomised controlled trial
Table 2. Characteristics of excluded reviews
Reason for exclusion Reviews excluded (n = 15)
Does not include RCTs including parallel-group, cluster, or fac-
torial RCTs
Petrozzino 2010
Does not include studies that include patients presenting to pri-
mary care with acute respiratory infection
Patel 2007
Does not include interventions aimed at health professional with
the primary goal of reducing antibiotic prescribing
Andrews 2012; Arroll 2003; Petrozzino 2010; Spurling 2013
Does not investigate the effect of the intervention on antibiotic
prescribing compared to usual care or control
Andrews 2012; Arroll 2003;Rausch 2009; Schuetz2011; Spurling
2013
Duplication of included review Schuetz 2013 (duplicate of included Cochrane review Schuetz
2012)
Data were not reported at an individual-study basis. Gross 2001; van der Velden 2012
No novel coverage in addition to included Cochrane Review Cooke 2015; Engel 2012 (both fully overlap with Aabenhus 2014
in terms of included trials)
Rated as high risk in ROBIS quality assessment Ranji 2008; van der Does 2016; Vodicka 2013
RCT: randomised controlled trial
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Table 3. Characteristics of included reviews
Review Date assessed
as up-to-date
Included
RCTs (n)*
Population* Intervention Comparison
intervention
Primary out-
come*
Limitations
Aabenhus
2014
Around
January 2014
6 Patients pre-
senting with
ARI in general
practice
Point-of-
care tests in-
cluding C-re-
active protein,
procalcitonin,
and white
blood cell
count
Usual care Number of
patients given
antibiotic pre-
scription at in-
dex consulta-
tion and at
28 days’ fol-
low-up
Small number
of included
studies
Arnold 2005 December
2002
5 Pa-
tients present-
ing with RTI
in primary
care
Pro-
fessional inter-
ventions in the
Cochrane
Effective Prac-
tice and Or-
ganisation
of Care
Group. To in-
clude: educa-
tion materials
for clinician,
educational
meetings, lo-
cal consensus
processes, ed-
ucational out-
reach visits, lo-
cal
opinion lead-
ers, patient-
mediated in-
ter-
ventions, au-
dit and feed-
back, re-
minders, mar-
keting, mass
media, finan-
cial interven-
tions
Usual care
or other inter-
vention
De-
cision to pre-
scribe an an-
tibiotic or not
None
reported.
Boonacker
2010
February
2009
2 Children pre-
senting
with URTI in
primary care
Com-
puterised evi-
dence-based
decision sup-
port, develop-
Usual care Antibi-
otic prescrib-
ing and re-
duced propor-
Poten-
tial for publi-
cation bias in
search. Cost-
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Table 3. Characteristics of included reviews (Continued)
ment of clini-
cal practice
guide-
lines, and edu-
cational mate-
rials for clini-
cian
tion of pre-
scribed antibi-
otic courses
effective-
ness not eval-
uated. Insuffi-
cient informa-
tion to judge
risk of bias in
some areas
Coxeter 2015 December
2014
9 (reported in
10 papers)
Pa-
tients present-
ing with ARI
in primary
care
Shared deci-
sion making
Usual care
or other inter-
vention
Prescriptionof
antibiotics
Intraclass cor-
relation was
imputed for 2
studies.
de Bont 2015 April 2014 2 Patients pre-
senting with
ARI in general
practice
Patient infor-
mation leaflets
(PIL)
for use by clin-
icians in con-
sultations
No PIL Antibiotic
prescribing
Studies were at
high risk of
bias as blind-
ing to the in-
tervention was
not pos-
sible. Patients
included and
outcomes as-
sessed were di-
verse. No het-
ero-
geneity analy-
sis was con-
ducted
Doan 2014 Around July
2014
3 Children pre-
sent-
ing with ARI
in the emer-
gency depart-
ment
Rapid
viral diagnosis
by testing
No test or test
re-
sult not made
known to clin-
ician
Antibi-
otic prescrib-
ing rate
None
reported.
Huang 2013 June 2013 6 (reported in
7 papers)
Patients pre-
senting with
ARI in general
practice
C-reactive
protein point-
of-care test
No test or
usual care, or
both
Antibiotic
prescribing at
index consul-
tation
Meta-analy-
sis is based on
aggregate data
rather than in-
dividual-
participant
data, so diffi-
cult to explore
sources of het-
erogeneity
25Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an
overview of systematic reviews (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Characteristics of included reviews (Continued)
Schuetz 2012 2011 9 Adults
presenting
with ARI in
primary care
Strategies to
initiate or dis-
continue an-
tibiotic ther-
apy
based on pro-
calcitonin cut-
off ranges
No use of pro-
calcitonin
Initiation of
antibiotics
Vari-
ation in pa-
tient popula-
tions/settings
and treatment
failure was
defined differ-
ently for each
context
*relevant to this overview
ARI: acute respiratory infection
RCT: randomised controlled trial
RTI: respiratory tract infection
URTI: upper respiratory tract infection
Table 4. Quality of included studies: the proportion of studies within each review judged as at low risk of bias by review
authors according to ’Risk of bias’ domains
Review ID Random se-
quence gen-
eration
Allocation
concealment
Blinding of
participants
Blinding of
outcome as-
sessment
Incomplete
outcome data
Selective
reporting
Other bias
Aabenhus
2014
(6 RCTs)
5 studies*
(83%1)
1 study
(17%)
None
(0%)
5 studies*2
(83%)
6 studies
(100%)
4 studies
(67%)
1 study
(17%)
Arnold 2005
(5 RCTs)
Not reported 1 study
(20%)
Not reported 3 studies
(60%)
2 studies
(20%)
Not reported Not reported
Boonacker
2010
(2 RCTs)
2 studies
(100%)
1 study
(50%)
2 studies
(100%)
2 studies
(100%)
2 studies
(100%)
2 studies
(100%)
1 study
(34%)
Coxeter 2015
(10 RCTs2)
10 studies
(100%)
7 studies
(70%)
1 study
(10%)
7 studies
(70%)
9 studies
(90%)
10 studies
(100%)
7 studies
(70%)
de Bont 2015
(2 RCTs)
1 study
(50%)
2 studies
(100%)
None
(0%)
1 study
(50%)
2 studies
(100%)
2 studies
(100%)
Not reported
Doan 2014
(3 RCTs)
3 studies
(100%)
1 study
(34%)
None
(0%)
None
(0%)
2 studies
(67%)
3 studies
(100%)
3 studies
(100%)
Huang 2013
(7 studies3)
1 study*
(14%)
1 study
(14%)
None
(0%)
None*
(0%)
5 studies
(71%)
7 studies
(100%)
None
(0%)
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Table 4. Quality of included studies: the proportion of studies within each review judged as at low risk of bias by review
authors according to ’Risk of bias’ domains (Continued)
Schuetz 2012
(9 RCTs)
7 studies
(78%)
4 studies
(33%)
None
(0%)
4 studies
(33%)
9 studies
(100%)
9 studies
(100%)
3 studies
(43%)
RCT: randomised controlled trial
*Results differ between reviews where RCTs had significant overlap. Aabenhus 2014 provided more detailed reporting of risk of bias
than Huang 2013.
1Percentages report the proportion of RCTs within each review judged as at low risk of bias on the relevant item.
2Aabenhus 2014 reported blinding for primary outcome of antibiotic prescribing separately to blinding for other outcomes.
3Coxeter 2015 and Huang 2013 reported results for 10 and 7 publications of 9 and 6 original RCTs, respectively.
Table 5. Overview of results
Interventions to reduce antibiotic prescribing in the management of acute respiratory infections for patients presenting in
primary care
Outcome Intervention
and compari-
son interven-
tion
Contributing
reviews
Relative
effect (95%
CI) of an an-
tibiotic being
prescribed1
Number of participants
(RCTs)
Quality of the
evidence
(GRADE)*
Comments
Change in
antibi-
otic prescrip-
tions for ARI
(at consulta-
tion)
CRP point-of-
care test /
usual care
Aabenhus
2014
RR 0.78 (0.66 to 0.92) 3284 (6) Moderate6 CRP point-of-
care
testing proba-
bly reduces
antibiotic pre-
scribing in
general prac-
tice compared
to usual care.
However,
CRP testing
may have little
or no effect on
prescribing in
emergency de-
partments
Huang 2013 General practice setting (indi-
vidual trials reported):
RR 0.57 (0.44 to 0.74)
RR 0.58 (0.45 to 0.74)
Emergency department setting:
RR 1.23 (0.76 to 1.99)
330 (1)
379 (1)
131 (1)
Moderate3*
Low3,6*
Rapid viral di-
agnosis / usual
care
Doan 2014 RR 0.86 (0.61 to 1.22) 891 (3) Low3,6* Rapid
viral diagnosis
may hav little
o no effect o
antibioti pr
scribing com-
pared to usual
care
Procalcitonin-
guided
management /
usual care
Schuetz 2012 General practice setting:
adjusted OR 0.10 (0.07 to 0.
14)
Emergency department setting:
adjusted OR 0.34 (0.28 to 0.
43)
1008 (2)
2605 (7)
Moderate3
Moderate3
Procalcitonin-
guided man-
agement prob-
ably re-
duces antibi-
otic prescrib-
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Table 5. Overview of results (Continued)
ing in general
practice
and the emer-
gency depart-
ment com-
pared to usual
care
Clinician edu-
cation and de-
cision support
/ usual care
Boonacker
2010
Difference in behaviour change
-12% (0.095)
OR 0.60 (0.43 to 0.83)
Not reported
(1)
Not reported
(1)
Very low3,5,6* We are uncer-
tain
about whether
clinician edu-
cation and de-
cision support
reduces
antibiotic pre-
scribing com-
pared to usual
care
Patient infor-
mation leaflets
/ usual care
de Bont 2015 RR 0.47 (0.36 to 0.64)
RR 1.15 (0.89 to 1.48)
558 (1)
1014 (1)
Very low3,4,6* We are uncer-
tain
as to whether
patient infor-
mation leaflets
reduce antibi-
otic prescrib-
ing compared
to usual care
Shared deci-
sion making /
usual care
Coxeter 2015 No pooled analysis of all trials:
OR 0.44 (0.26 to 0.75)
RR 0.64 (0.49 to 0.84)
adjusted risk difference -18.44
(-27.24 to -9.65)
3274 (3)
4623 (2)
481,807 (4)
Moderate3 Shared de-
cision making
probably re-
duces antibi-
otic prescrib-
ing compared
to usual care
Multifaceted interventions
Printed educa-
tional materi-
als for clini-
cians
and reminders
/ usual care
Arnold 2005 Individual trials reported:
OR 0.44 (0.21 to 0.92)
OR 0.57 (0.27 to 1.17)
Not reported
(1)
Not reported
(1)
Very low3,4,6* We are uncer-
tain
as to whether
printed educa-
tional materi-
als reduce
antibiotic pre-
scribing com-
pared to usual
care
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Table 5. Overview of results (Continued)
Audit
and feedback
(with patient
education ma-
terials) / usual
care
Arnold 2005 Difference in
behaviour change: -7.3% (audit
and feedback alone)
Difference in behaviour
change: -7.2% (audit and feed-
back with patient materials)
Not reported
(1)
Low3,6* Audit and
feedback may
reduce antibi-
otic prescrib-
ing compared
to usual care
Edu-
cational mate-
rials and edu-
cational meet-
ings for clini-
cian and
patient educa-
tion materials
/ usual care
Arnold 2005 Difference in
behaviour
change:
16% (8% to
23%) (age 3 to
36 months)
Difference in
behaviour
change:
12% (2% to
21%) (age 36
to 72 months)
Not reported (1) Low3,6* Educational
materials and
meetings may
reduce antibi-
otic prescrib-
ing compared
to usual care
Edu-
cational mate-
rials, comput-
erised decision
support, pro-
fessional de-
velopment, fi-
nancial
incentive, and
patient educa-
tion materials
/ usual care
Arnold 2005 Difference in
behaviour
change: -3.0%
(P = 0.03)
Not reported (1) Low3,6* These inter-
ventions may
slightly reduce
antibiotic pre-
scribing com-
pared to usual
care
Change in
antibi-
otic prescrip-
tions for ARI
(within 28
days of con-
sultation)
CRP point-of-
care test /
usual care
Aabenhus
2014
RR 0.80 (0.67 to 0.96) 3284 (6) Moderate6 CRP point-of-
care
testing proba-
bly reduces
antibiotic
prescribing for
up to 28 days
following con-
sultation com-
pared to usual
care
Adverse
events
CRP point-of-
care test /
usual care
Aabenhus
2014
RR 2.45 (0.65 to 9.19) 4264 (1) Moderate6 CRP point-of-
care
testing proba-
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Table 5. Overview of results (Continued)
bly results in
little or no dif-
ference in
adverse events
compared to
usual care
Symp-
tom duration
or severity
CRP point-of-
care test /
usual care
Aabenhus
2014
At 7 days: RR 1.03 (0.93 to 1.
14)
At 28 days: RR 0.94 (0.69 to 1.
28)
1309 (3)
849 (3)
Moderate6 CRP point-of-
care test-
ing probably
results in little
or no differ-
ence in symp-
tom duration
or
severity com-
pared to usual
care
Health-
related qual-
ity of life
Procalcitonin-
guided
management /
usual care
Schuetz 2012 Adjusted difference in days 0.
05, -0.46 to 0.56, P = 0.854
1008 (2) Moderate3 Procalcitonin-
guided man-
agement prob-
ably results in
little or no dif-
fer-
ence in health-
related quality
of life com-
pared to usual
care
Patient satis-
faction
CRP point-of-
care test /
usual care
Aabenhus
2014
RR 0.79 (0.57 to 1.08) 689 (2) Moderate6 CRP point-of-
care
testing proba-
bly results in
little or no dif-
ference in pa-
tient satisfac-
tion compared
to usual care
Shared deci-
sion making /
usual care
Coxeter 2015 RR 0.86 (0.57 to 1.30) 1110 (2) Low3,6 Shared de-
cision making
may result in
little or no dif-
ference in pa-
tient satisfac-
tion compared
to usual care
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Table 5. Overview of results (Continued)
Man-
agement fail-
ure - recon-
sultation and
treatment
failure
CRP point-of-
care test /
usual care
Aabenhus
2014
RR 1.08 (0.93 to 1.27) 5132 (4) Moderate6 CRP point-of-
care
testing proba-
bly results in
little or no dif-
ference in re-
consulta-
tion compared
with usual care
at 28 days’ fol-
low-up
Shared deci-
sion making /
usual care
Coxeter 2015 RR 0.87 (0.74 to 1.03) 1860 (4) Moderate3 Shared
decision mak-
ing probably
results in little
or no differ-
ence in recon-
sultation com-
pared to usual
care
Patient infor-
mation leaflets
/ usual care
de Bont 2015 Individual tri-
als reported:
RR 0.80 (0.52
to 1.21)
RR 0.70 (0.53
to 0.91)
558 (1)
1014 (1)
Very low3,4,6* We are uncer-
tain as
to whether pa-
tient interven-
tion leaflets re-
sult in a differ-
ence in recon-
sultation com-
pared to usual
care
Rapid viral di-
agnosis / usual
care
Doan 2014 RR 0.86 (0.59
to 1.25)
200 (1) Low3,6* Rapid viral di-
agnostics may
result in little
or no differ-
ence in recon-
sultation rela-
tive to usual
care
Procalcitonin-
guided
management /
usual care
Schuetz 2012 Treatment
failure in gen-
eral practice2:
adjusted OR
0.95 (0.73 to
1.24)
Treat-
1008 (2)
2605 (7)
Moderate3 Procalcitonin-
guided man-
agement prob-
ably results in
little or no dif-
ference in
treatment fail-
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Table 5. Overview of results (Continued)
ment failure in
emergency de-
partment2:
adjusted OR
0.76 (0.61 to
0.95)
ure in general
practice com-
pared to nor-
mal care
Procalcitonin-
guided man-
agement prob-
ably
reduces treat-
ment failure in
the emergency
department
compared to
usual care
GRADE quality of evidence and definitions
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate
Very low quality: Any estimate of effect is very uncertain.
*GRADE criteria were applied retrospectively to outcomes when GRADE was not used by the original review authors
ARI: acute respiratory infection; CI: confidence interval; CRP: C-reactive protein; OR: odds ratio; RCT: randomised controlled
trial; RR: risk ratio
1Effect estimates are shown as reported in the original reviews. Multiple effect estimates are reported for some outcomes when reviews
did not pool data from trials but reported individual trials separately.
2Schuetz 2012 defined treatment failure in primary care as death, hospitalisation, ARI-specific complications (e.g. empyema for lower
ARIs, meningitis for upper ARIs), recurrent or worsening infection, and still having ARI-associated discomfort at 30 days. Treatment
failure in the emergency setting was defined as death, intensive care unit admission, rehospitalisation after index hospital discharge, ARI-
associated complications (e.g. empyema or acute respiratory distress syndrome for lower ARIs), and recurrent or worsening infection
within 30 days of follow-up.
3Quality of evidence was downgraded one level because of risk of bias: inadequate methods of sequence generation, lack of allocation
concealment, and/or lack of blinding of participants.
4Quality of evidence was downgraded one level because of inconsistency: heterogeneity in results likely due to differences in the
interventions trialled across studies.
5Quality of evidence was downgraded one level because of risk of publication bias: review only reported effective interventions.
6Quality of evidence was downgraded one level due to imprecision because trials included relatively few patients or when the confidence
interval showed substantial variation in the effect of the intervention.
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A P P E N D I C E S
Appendix 1. Search strategies
MEDLINE
1 exp Anti-Bacterial Agents/
2 (Antibacterial? or Anti-bacterial? or Antibiotic? or Anti-biotic? or Macrolide? or beta-Lactam? or Antimicrobial? or Anti-microbial?
or Penicillin or Methicillin or ampicillin or azithromycin or Cephalexin).tw.
3 1 or 2
4 exp Respiratory Tract Infections/ or Nasopharyngitis/ or exp Sinusitis/ or Rhinitis/ or Laryngitis/ or Bronchitis/ or exp bronchiolitis/
or bronchiolitis, viral/ or exp Pneumonia/ or exp Pleurisy/ or Cough/ or Sneezing/ or exp Otitis Media/ or Earache/ or Influenza,
Human/ or Common Cold/
5 (((respiratory or chest) adj3 (infect* or inflam*)) or (ARI or ARTI or URTI or LRTI) or (nasopharyngit* or rhinopharyngit*) or
sinusit* or (nasosinusit* or rhinosinusit*) or rhinit* or (rhinorrhoea or rhinorrhea) or ((runny or running or discharg* or congest* or
blocked or stuff* or dripping) adj2 (nose* or nasal)) or pharyngit* or sore throat* or (throat* adj3 (inflam* or infect*)) or tonsillit* or
laryngit* or croup or (pseudocroup or tracheobronchit* or laryngotracheobronchit*) or (bronchit* or bronchiolit*) or (pneumon* or
pleuropneumon* or bronchopneumon*) or pleurisy or (cough* or sneez*) or (otitis media or aom or ome) or earache* or (influenza*
or flu) or common cold*).tw.
6 4 or 5
7 exp Drug Prescriptions/ or Inappropriate prescribing/ or Practice Patterns, Physicians/
8 (prescrib* or prescrip* or stewardship or Antibiotic therapy or Antibiotic treatment).tw.
9 7 or 8
10 (Delay or Delayed or Reduce or Reduces or Reducing or Reduced or Discontinue or Stopping).tw.
11 Ambulatory Care/ or exp Ambulatory Care Facilities/ or exp general practice/ or exp general practitioners/ or exp physicians, family/
or exp physicians, primary care/ or exp Primary Health Care/ or exp Office Visits/ or Outpatients/ or exp Emergency Service, Hospital/
or Emergency Medical Services/
12 ((ambulatory adj3 (care or setting? or facilit* or ward? or department? or service?)) or (practi* or physician? or doctor? or Clinician?)
or (primary care or primary health care or primary healthcare) or (after hour? or afterhour? or “out of hour?” or ooh) or (clinic? or visit?)
or ((health* or medical) adj2 (center? or centre?)) or outpatient? or (emergency adj3 (care or setting? or facilit* or ward? or department?
or service?))).tw.
13 11 or 12
14 meta-analysis.mp,pt. or review.pt. or search*.tw.
15 3 and 6 and 9 and 10 and 13 and 14
Embase
1 exp *antibiotic agent/
2 (Antibacterial? or Anti-bacterial? or Antibiotic? or Anti-biotic? or Macrolide? or beta-Lactam? or Antimicrobial? or Anti-microbial?
or Penicillin or Methicillin or ampicillin or azithromycin or Cephalexin).tw.
3 1 or 2
4 exp *respiratory tract infection/ or *ear infection/ or exp *otitis media/ or *coughing/ or *sneezing/ or *otalgia/
5 (((respiratory or chest) adj3 (infect* or inflam*)) or (ARI or ARTI or URTI or LRTI) or (nasopharyngit* or rhinopharyngit*) or
sinusit* or (nasosinusit* or rhinosinusit*) or rhinit* or (rhinorrhoea or rhinorrhea) or ((runny or running or discharg* or congest* or
blocked or stuff* or dripping) adj2 (nose* or nasal)) or pharyngit* or sore throat* or (throat* adj3 (inflam* or infect*)) or tonsillit* or
laryngit* or croup or (pseudocroup or tracheobronchit* or laryngotracheobronchit*) or (bronchit* or bronchiolit*) or (pneumon* or
pleuropneumon* or bronchopneumon*) or pleurisy or (cough* or sneez*) or (otitis media or aom or ome) or earache* or (influenza*
or flu) or common cold*).tw.
6 4 or 5
7 *prescription/ or inappropriate prescribing/ or *antibiotic therapy/
8 (prescrib* or prescrip* or stewardship or Antibiotic therapy or Antibiotic treatment).tw.
9 7 or 8
10 (Delay or Delayed or Reduce or Reduces or Reducing or Reduced or Discontinue or Stopping).tw.
11 ambulatory care/ or outpatient department/ or outpatient/ or general practice/ or general practitioner/ or primary medical care/ or
primary health care/ or emergency ward/ or emergency health service/
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12 ((ambulatory adj3 (care or setting? or facilit* or ward? or department? or service?)) or (practi* or physician? or doctor? or Clinician?)
or (primary care or primary health care or primary healthcare) or (after hour? or afterhour? or “out of hour?” or ooh) or (clinic? or visit?)
or ((health* or medical) adj2 (center? or centre?)) or outpatient? or (emergency adj3 (care or setting? or facilit* or ward? or department?
or service?))).tw.
13 11 or 12
14 meta-analys:.mp. or search:.tw. or review.pt.
15 3 and 6 and 9 and 10 and 13 and 14
CINAHL
1 (MH “Antibiotics+”)
2 TI ( Antibacterial? or Anti-bacterial? or Antibiotic? or Anti-biotic? orMacrolide? or beta-Lactam? or Antimicrobial? or Anti-microbial?
or Penicillin orMethicillin or ampicillin or azithromycin orCephalexin )ORAB (Antibacterial? or Anti-bacterial? or Antibiotic? or Anti-
biotic? or Macrolide? or beta-Lactam? or Antimicrobial? or Anti-microbial? or Penicillin or Methicillin or ampicillin or azithromycin
or Cephalexin )
3 S1 OR S2
4 (MH “Respiratory Tract Infections+”) OR (MH “Otitis Media+”) OR (MH “Cough”) OR (MH “Sneezing”) OR (MH “Earache”)
5 TI ( (((respiratory or chest) N3 (infect* or inflam*)) or (ARI or ARTI or URTI or LRTI) or (nasopharyngit* or rhinopharyngit*) or
sinusit* or (nasosinusit* or rhinosinusit*) or rhinit* or (rhinorrhoea or rhinorrhea) or ((runny or running or discharg* or congest* or
blocked or stuff* or dripping) N2 (nose* or nasal)) or pharyngit* or sore throat* or (throat* N3 (inflam* or infect*)) or tonsillit* or
laryngit* or croup or (pseudocroup or tracheobronchit* or laryngotracheobronchit*) or (bronchit* or bronchiolit*) or (pneumon* or
pleuropneumon* or bronchopneumon*) or pleurisy or (cough* or sneez*) or (otitis media or aom or ome) or earache* or (influenza*
or flu) or common cold*) ) OR AB ( (((respiratory or chest) N3 (infect* or inflam*)) or (ARI or ARTI or URTI or LRTI) or
(nasopharyngit* or rhinopharyngit*) or sinusit* or (nasosinusit* or rhinosinusit*) or rhinit* or (rhinorrhoea or rhinorrhea) or ((runny
or running or discharg* or congest* or blocked or stuff* or dripping) N2 (nose* or nasal)) or pharyngit* or sore throat* or (throat* N3
(inflam* or infect*)) or tonsillit* or laryngit* or croup or (pseudocroup or tracheobronchit* or laryngotracheobronchit*) or (bronchit*
or bronchiolit*) or (pneumon* or pleuropneumon* or bronchopneumon*) or pleurisy or (cough* or sneez*) or (otitis media or aom or
ome) or earache* or (influenza* or flu) or common cold*) )
6 S4 OR S5
7 (MH “Prescribing Patterns”) OR (MH “Inappropriate Prescribing”)
8 TI ( prescrib* or prescrip* or stewardship or “Antibiotic therapy” or “Antibiotic treatment” ) OR AB ( prescrib* or prescrip* or
stewardship or “Antibiotic therapy” or “Antibiotic treatment” )
9 S7 OR S8
10 Delay or Delayed or Reduce or Reduces or Reducing or Reduced or Discontinue or Stopping
11 (MH “Ambulatory Care”) OR (MM “Ambulatory Care Facilities”) OR (MH “Family Practice”) OR (MH “Physicians, Family”) OR
(MH “Physicians, Emergency”) OR (MH “Primary Health Care”) OR (MH “Emergency Service”) OR (MH “Emergency Medicine”)
OR (MH “Outpatient Service”) OR (MH “Outpatients”)
12 TI ( ((ambulatory N3 (care or setting? or facilit* or ward? or department? or service?)) or (practi* or physician? or doctor? or
Clinician?) or (primary care or primary health care or primary healthcare) or (after hour? or afterhour? or “out of hour?” or ooh) or
(clinic? or visit?) or ((health* or medical) N2 (center? or centre?)) or outpatient? or (emergency N3 (care or setting? or facilit* or ward?
or department? or service?))) ) OR AB ( ((ambulatory N3 (care or setting? or facilit* or ward? or department? or service?)) or (practi*
or physician? or doctor? or Clinician?) or (primary care or primary health care or primary healthcare) or (after hour? or afterhour? or
“out of hour?” or ooh) or (clinic? or visit?) or ((health* or medical) N2 (center? or centre?)) or outpatient? or (emergency N3 (care or
setting? or facilit* or ward? or department? or service?))) )
13 S11 OR S12
14 S3 AND S6 AND S9 AND S10 AND S13
15 S3 AND S6 AND S9 AND S10 AND S13 - Limiters - Clinical Queries: Review - Best Balance
PsycINFO
1 exp antibiotics/
2 (Antibacterial? or Anti-bacterial? or Antibiotic? or Anti-biotic? or Macrolide? or beta-Lactam? or Antimicrobial? or Anti-microbial?
or Penicillin or Methicillin or ampicillin or azithromycin or Cephalexin).tw.
3 1 or 2
4 exp respiratory tract disorders/ or exp influenza/
5 (((respiratory or chest) adj3 (infect* or inflam*)) or (ARI or ARTI or URTI or LRTI) or (nasopharyngit* or rhinopharyngit*) or
sinusit* or (nasosinusit* or rhinosinusit*) or rhinit* or (rhinorrhoea or rhinorrhea) or ((runny or running or discharg* or congest* or
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blocked or stuff* or dripping) adj2 (nose* or nasal)) or pharyngit* or sore throat* or (throat* adj3 (inflam* or infect*)) or tonsillit* or
laryngit* or croup or (pseudocroup or tracheobronchit* or laryngotracheobronchit*) or (bronchit* or bronchiolit*) or (pneumon* or
pleuropneumon* or bronchopneumon*) or pleurisy or (cough* or sneez*) or (otitis media or aom or ome) or earache* or (influenza*
or flu) or common cold*).tw.
6 4 or 5
7 exp “prescribing (drugs)”/
8 (prescrib* or prescrip* or stewardship or Antibiotic therapy or Antibiotic treatment).tw.
9 7 or 8
10 (Delay or Delayed or Reduce or Reduces or Reducing or Reduced or Discontinue or Stopping).tw.
11 outpatient treatment/ or outpatients/ or exp Primary Health Care/ or exp General Practitioners/
12 ((ambulatory adj3 (care or setting? or facilit* or ward? or department? or service?)) or (practi* or physician? or doctor? or Clinician?)
or (primary care or primary health care or primary healthcare) or (after hour? or afterhour? or “out of hour?” or ooh) or (clinic? or visit?)
or ((health* or medical) adj2 (center? or centre?)) or outpatient? or (emergency adj3 (care or setting? or facilit* or ward? or department?
or service?))).tw.
13 11 or 12
14 (control: or effectiveness or risk:).tw.
15 3 and 6 and 9 and 10 and 13 and 14
Web of Science
1 486,465 TOPIC: (Antibacterial* or Anti-bacterial* or Antibiotic* or Anti-biotic* or Macrolide* or beta-Lactam* or Antimicrobial*
or Anti-microbial* or Penicillin or Methicillin or ampicillin or azithromycin or Cephalexin)
2 415,544 TOPIC: ((((respiratory or chest) NEAR/3 (infect* or inflam*)) or ARI or ARTI or URTI or LRTI or nasopharyngit* or
rhinopharyngit* or sinusit* or nasosinusit* or rhinosinusit* or rhinit* or rhinorrhoea or rhinorrhea or ((runny or running or discharg*
or congest* or blocked or stuff* or dripping) NEAR/2 (nose* or nasal)) or pharyngit* or “sore throat*” or (throat* NEAR/3 (inflam* or
infect*)) or tonsillit* or laryngit* or croup or pseudocroup or tracheobronchit* or laryngotracheobronchit* or bronchit* or bronchiolit*
or pneumon* or pleuropneumon* or bronchopneumon* or pleurisy or cough* or sneez* or “otitis media” or aom or ome or earache*
or influenza* or flu or “common cold*”))
3 2,388,774 TOPIC: ((ambulatory NEAR/3 (care or setting* or facilit* or ward* or department* or service*)) or practi* or physician*
or doctor* or Clinician* or “primary care” or “primary health care” or “primary healthcare” or “after hour*” or afterhour* or “out of
hour*” or ooh or clinic or clinics or visit or visits or ((health* or medical) NEAR/2 (center* or centre*)) or outpatient* or (emergency
NEAR/3 (care or setting* or facilit* or ward* or department* or service*)))
4 3,612,461 TOPIC: (Delay or Delayed or Reduce or Reduces or Reducing or Reduced or Discontinue or Stopping)
5 225,166 TOPIC: (prescrib* or prescrip* or stewardship or “Antibiotic therapy” or “Antibiotic treatment”)
6 169 (#5 AND #4 AND #3 AND #2 AND #1) AND DOCUMENT TYPES: (Review)
7 104,119 (TS=(meta-analysis OR “systematic review” OR search*)) AND DOCUMENT TYPES: (Review)
8 65 #7 AND #5 AND #4 AND #3 AND #2 AND #1
9 169 #8 OR #6
Appendix 2. Characteristics of reviews awaiting classification
Review Included trials (n) Population Intervention Comparison inter-
vention
Primary outcome
Hu 2016 13 Children presenting
with upper respira-
tory infections in
primary care
Approaches target-
ing clinicians or par-
ents of child pa-
tients, or both
Usual care Antibiotic prescrib-
ing
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(Continued)
Martinez-Gonzalez
2017
(protocol only)
Unknown Adults and children
presenting in pri-
mary care with res-
piratory tract infec-
tions
Any interven-
tion aimed at im-
proving the quality
of prescribing and
use of antibiotics
in primary care pa-
tients with respira-
tory tract infections
Unknown Antibiotic prescrib-
ing and use
McDonagh 2016 88 randomised con-
trolled trials
Adult or child pa-
tients present-
ing with acute res-
piratory tract infec-
tions
Any interven-
tion designed to im-
prove antibiotic use
aimed at clinicians,
patients, or the pub-
lic
Usual care or alter-
native intervention
Antibiotic prescrib-
ing and use
O’Sullivan 2016 2 Adults
or children present-
ing with acute up-
per respiratory tract
infection in primary
care
Written
information for pa-
tients (or parents of
child patients)
Usual care or alter-
native intervention
Antibiotic prescrib-
ing and use
Appendix 3. Initial ROBIS quality assessment on 11 reviews for potential inclusion in the overview
Review ID ROBIS assessment
Phase 2 domains Phase 3
1. Study eligibility
criteria
2. Identi-
fication and selec-
tion of studies
3. Data collec-
tion and study ap-
praisal
4. Synthesis and
findings
5. Risk of bias
Aabenhus 2014 Low risk Low risk Low risk Low risk Low risk
Arnold 2005 Low risk Low risk Low risk High risk
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
Low risk
A. Interpretation of
findings addressed
all concerns.
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
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(Continued)
ing results on the ba-
sis of their statistical
significance
Boonacker 2010 Low risk Low risk Low risk High risk
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
Low risk
A. Interpretation of
findings addressed
all concerns.
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
ing results on the ba-
sis of their statistical
significance
Coxeter 2015 Low risk Low risk Low risk High risk
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
Low risk
A. Interpretation of
findings addressed
all concerns.
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
ing results on the ba-
sis of their statistical
significance
de Bont 2015 Low risk Low risk Low risk High risk
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
Low risk
A. Interpretation of
findings addressed
all concerns.
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
ing results on the ba-
sis of their statistical
significance
Doan 2014 Low risk Low risk Low risk Low risk Low risk
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(Continued)
Huang 2013 Low risk Low risk Low risk High risk
4.5 -No funnel plots
or sensitivity analy-
sis presented.
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
Low risk
A. Interpretation of
findings addressed
all concerns.
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
ing results on the ba-
sis of their statistical
significance
Ranji 2008 High risk
1.5 - Non-
English studies were
excluded.
High risk
2.4 - Non-
English studies were
excluded.
High risk
3.4 - Review authors
provided an assess-
ment of study qual-
ity but not ’Risk of
bias’ assessment. 3.
5 - Review authors
do not specify which
researchers assessed
study quality
High risk
4.5 -No funnel plots
or sensitivity analy-
sis presented.
4.6 - Bias in stud-
ies is not assessed
and not considered
in analysis
High risk
A. Review authors
do not discuss ex-
clusion of non-En-
glish studies as a lim-
itation. Review au-
thors do not discuss
risk of bias or limita-
tions in assessment
of study quality. As-
sessment of study
quality is unclear.
Review authors do
discuss limitations
in doing meta-anal-
ysis
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review au-
thors may overem-
phasise results based
on population effect
size
Schuetz 2012 Low risk Low risk Low risk Low risk Low risk
van der Does 2016 High risk
1.5 - Non-
English studies were
excluded.
High risk
2.2 - No
other search meth-
ods in addition to
databases were used
to identify reports
2.4 - Non-
High risk
3.1 - Review authors
do not specify which
re-
searchers performed
data extraction
3.5 - Review authors
High risk
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
High risk
A. Review authors
do not discuss ex-
clusion of non-En-
glish studies or not
using othermethods
to search for papers
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(Continued)
English studies were
excluded.
do not specify which
re-
searchers performed
quality assessment
as limitations. Re-
view authors did not
comment on meth-
ods of data extrac-
tion or quality as-
sessment as poten-
tial limitations. Re-
view authors do dis-
cuss ’Risk of bias’ as-
sessment
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
ing results on the ba-
sis of their statistical
significance
Vodicka 2013 High risk
1.5 - Searchwas lim-
ited to studies con-
ducted in high-in-
come
countries only, for
which a reason was
not provided
High risk
2.1 - Only pub-
lished studies were
included.
2.5 - Only 1 author
screened titles and
abstracts.
Low risk High risk
4.6 - Quality of
studies is not as-
sessed in any analy-
sis.
High risk
A.
Review authors ac-
knowledge focus on
high-income coun-
tries and published
studies in their lim-
itations section. Re-
view authors do not
discuss data screen-
ing by 1 author
B. Rel-
evance of identified
studies was appro-
priately considered
C. Review authors
avoided emphasis-
ing results on the ba-
sis of their statistical
significance
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WH A T ’ S N E W
Date Event Description
30 August 2017 New search has been performed We re-ran the search on 19May 2017, screened the results and placed the three
reviews that we identified from this updated search in Appendix 2: Character-
istics of reviews awaiting classification. We will incorporate these reviews in the
next version of this overview, as appropriate
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